CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings Call Transcript
Operator: Good day, and welcome to the CorMedix Third Quarter 2025 Earnings and Corporate Update Conference Call. [Operator Instructions] Please note this event is being recorded.
Cormedix Inc. (CRMD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,473,494 | $40,396,735 | +35% | 0.04% |
| 2. | Deerfield Management James E. Flynn | 3,323,833 | $38,656,178 | 0.59% | |
| 3. | Citadel Investment Group Ken Griffin | 1,717,087 | $19,969,722 | +1% | 0% |
| 4. | Deep Track Capital David Kroin | 500,000 | $5,815,000 | 0.16% | |
| 5. | Royce & Associates Chuck Royce | 441,312 | $5,132,459 | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.02 | 25,000 | $275,500.00 | 201,034 | 2025-10-23 | Filing | |
| $9.99 | 1,500 | $14,984.85 | 52,011 | 2024-10-31 | Filing | |
| $3.74 | 13,561 | $50,718.14 | 352,839 | 2024-03-13 | Filing | |
| $3.30 | 3,000 | $9,900.00 | 15,250 | 2023-12-15 | Filing | |
| $3.45 | 3,000 | $10,350.00 | 12,250 | 2023-12-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.13 | 10,000 | $131,300.00 | 40,250 | 2025-09-12 | Filing | |
| $13.00 | 50,000 | $650,000.00 | 509,496 | 2025-09-12 | Filing | |
| $12.82 | 400 | $5,128.00 | 180,418 | 2025-09-09 | Filing | |
| $13.41 | 49,600 | $665,136.00 | 180,818 | 2025-09-09 | Filing | |
| $13.08 | 41,121 | $537,862.68 | 176,990 | 2025-09-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,688,303 | $66,154,964 | 0% | |
| 2. | 3,977,658 | $46,260,163 | 0% | |
| 3. | 1,835,621 | $21,348,272 | 0% | |
| 4. | 1,809,772 | $21,050,228 | 0% | |
| 5. | 1,090,908 | $12,687,259 | 0% |
News See All
Citizens JMP Reiterates a Buy Rating on CorMedix Inc. (CRMD)
CorMedix Inc. (NASDAQ:CRMD) is one of the best affordable biotech stocks to invest in now. On September 9, Citizens JMP analyst Jason Butler reiterated a Buy rating on CorMedix Inc.
12 Affordable Biotech Stocks to Invest In Now
On September 4, Mizuho healthcare strategist Jared Holz appeared on CNBC's ‘Power Lunch’ to talk about the changing sentiment in the healthcare sector, the differences in the biotech ETFs, and more...
Institutional Confidence Rises as CorMedix Inc. (CRMD) Hits Profitability
CorMedix Inc. (NASDAQ:CRMD) is among the fastest growing small cap stocks to buy. During the first quarter, the Swiss National Bank expanded its position in CorMedix Inc.
11 Fastest Growing Small Cap Stocks to Buy
These days, everyone is obsessed with speed: fast fashion, fast food, fast internet.
10 Overlooked Healthcare Stocks to Invest in
Most Americans have endured the frustration of having their health insurance denied, often with no resolution even after contacting carriers by phone and email. This can be changed by Dr.
Needham Maintains a Buy Rating on CorMedix (CRMD) With a $20 PT
CorMedix Inc. (NASDAQ:CRMD) is one of the top most undervalued biotech stocks to buy now. On August 7, Needham analyst Serge Belanger maintained a Buy rating on CorMedix Inc.
CorMedix Inc. (NASDAQ:CRMD) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the CorMedix Inc. Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
10 Most Undervalued Biotech Stocks to Buy Now
On July 25, Salveen Richter, Goldman Sachs' lead biotech analyst, appeared on CNBC’s ‘Squawk Box’ to talk about the state of the biotech sector and what to expect from the earnings season, among...
Hedge Fund Resource Center Billionaire Hedge Funds
